| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |